XtalPi
North America, Massachusetts, United States, Cambridge
Description
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Investor Profile
XtalPi has made 14 investments, with 10 in the past 12 months and 36% as lead.
Stage Focus
- Seed (36%)
- Series A (29%)
- Series Unknown (14%)
- Series B (7%)
- Angel (7%)
- Corporate Round (7%)
Country Focus
- China (50%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United States (14%)
- Switzerland (14%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Japan (7%)
Industry Focus
- Biotechnology
- Medical
- Pharmaceutical
- Biopharma
- Health Care
- Therapeutics
- Artificial Intelligence (Ai)
- Medical Device
- Alternative Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
